Benefit of Influenza Vaccination in Patients with Cardiovascular Disease
Keywords:
influenza, Vaccine, cardiovascular diseaseAbstract
Influenza remains a significant global health problem. The risks of complication and death from influenza are greater in comorbid groups, such as those suffering cardiovascular diseases. The true economic and social costs of influenza are far greater in these groups compared to healthy ones as these groups are vulnerable to complications and even death. Cardiovascular disease is the leading cause of death, both globally and in Indonesia. The relationship between cardiovascular events and seasonal influenza has been established. Influenza vaccination is one of the prevention methods that has proven effective in preventing influenza infection and reducing the risk of major cardiovascular events. In addition to being effective, influenza vaccination is also safe and well-tolerated by adults and the elderly. This review outlines the impacts of influenza and the benefits of influenza vaccine in groups with cardiovascular disease. Key words: influenza, vaccine, cardiovascular diseasesReferences
WHO. Influenza (seasonal). [Internet]. 2024 [cited August 2025]. Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
Roth GA, Mensah GA, Johnson CO, et al. GBD-NHLBI-JACC global burden of cardiovascular diseases writing group. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study. J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021.
Near AM, Tse J, Young-Xu Y, Hong DK, Reyes CM. Burden of influenza hospitalization among high-risk groups in the United States. BMC Health Serv Res. 2022 Sep 28;22(1):1209.
Ashraf MA, Raza MA, Amjad MN, et al. A comprehensive review of influenza B virus, its biological and clinical aspects. Front Microbiol. 2024;15.
Moghadami M. A Narrative Review of Influenza: A Seasonal and Pandemic Disease. Iran J Med Sci. 2017;42(1):2-13.
Djauzi PS, Rengganis I, Sundoro J, et al. Pedoman imunisasi pada orang dewasa. Jakarta: PIPInterna; 2024.
Gash CW, Blackburn R, Whitaker H, McMenamin J, et al. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. 2018:1701794.
Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009;9(10):601–10.
Boehme AK, Luna J, Kulick ER, Kamel H, Elkind MSV. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol. 2018;5(4):456–63.
Vejpongsa P, Kitkungvan D, Madjid M, et al. Outcomes of acute myocardial infarction in patients with influenza and other viral respiratory infections. Am J Med. 2019.
Goldstein E, Viboud C, Charu V, Lipsitch M. Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology. 2012;23 (6):829–38.
Skaarup KG, Modin D, Nielsen L, Jensen JUS, Biering-Sørensen T. Influenza and cardiovascular disease pathophysiology: strings attached. Eur Heart J Suppl. 2023 Feb 14;25(Suppl A):A5-A11.
Modin D, Jorgensen ME, Gislason G, et al. Influenza vaccine in heart failure. Circulation 2019;139(5):575–86).
MacIntyre CR, Mahimbo A, Moa AM, Barnes M. Influenza vaccine as a coronary intervention for prevention of myocardial infarction. Heart 2016;102(24):1953–6.
Mohseni H, Kiran A, Khorshidi R, Rahimi K. Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study. Eur Heart J. 2017;38(5):326–33.
Udell JA, Zawi R, Bhatt DL, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA. 2013;310 (16):1711–20.
Loeb M, Roy A, Dokainish H, et al. Influenza vaccine to prevent adverse vascular events investigators. Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2022 Dec;10(12):e1835-e1844.
Fröbert O, Götberg M, Erlinge D, et al. Influenza vaccination after myocardial infarction: A randomized, double-blind, placebo-controlled, Multicenter Trial. Circulation. 2021 Nov 2;144(18):1476-84.
Omidi F, Zangiabadian M, Shahidi Bonjar AH, Nasiri MJ, Sarmastzadeh T. Influenza vaccination and major cardiovascular risk: a systematic review and meta-analysis of clinical trials studies. Sci Rep. 2023 Nov 19;13(1):20235.
Behrouzi B, Bhatt DL, Cannon CP, Vardeny O, Lee DS, Solomon SD, Udell JA. Association of influenza vaccination with cardiovascular risk: A meta-analysis. JAMA Netw Open. 2022 Apr 1;5(4):e228873.
Gupta R, Quy R, Lin M, et al. Role of influenza vaccination in cardiovascular disease: Systematic review and meta-analysis. Cardiol Rev. 2023.
Modin D, Lassen MC, Claggett B, et al. Influenza vaccination and cardiovascular events in patients with ischaemic heart disease and heart failure: A meta-analysis. Eur J Heart Fail. 2023.
CDC. Who should and who should not get a flu vaccine. [Internet]. 2024 [cited August 2025]. Available from: https://www.cdc.gov/flu/professionals/vaccination/vax-summary.html.
CDC. Flu vaccine and people with egg allergies. [Internet]. Sep 2022 [cited July 2025]. Available from: https://www.cdc.gov/flu/professionals/vaccination/vax-summary.html.
Muñoz-Quiles C, López-Lacort M, Urchueguía A, Díez-Domingo J, Orrico-Sánchez A. Risk of cardiovascular events after influenza: a population-based self-controlled case series study, Spain, 2011–2018. The Journal of Infectious Diseases. 2024;230(3):e722–e731.
Davidson JA, Banerjee A, Douglas I, et al. Primary prevention of acute cardiovascular events by influenza vaccination: an observational study. European Heart Journal. 2023;44:610–20.
Kodaira M, Hasan MS, Grossman Y, et al. Risk of cardiovascular events after influenza infection-related hospitalizations in adults with congenital heart disease: A nationwide population-based study. American Heart Journal. 2024;278:93-105.
Barnes MB, Heywood AE, Mahimbo A, et al. Acute myocardial infarction and influenza: a meta-analysis of case–control studies. Heart. 2015;101:1738-47.
Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, Seet BT, Weinke T, Yu H. The disease burden of influenza beyond respiratory illness. Vaccine. 2021 Mar 15;39 (Suppl 1):A6-A14.
Kementerian Kesehatan Republik Indonesia. Surveilans Sentinel ILI-SARI. [Internet]. June 2025 [cited August 2025]. Available from: https://p2.kemkes.go.id/dash-ili-sari/
Lafond KE, Praptiningsih CY, Mangiri A, et al. Seasonal influenza and avian influenza A (H5N1) virus surveillance among inpatients and outpatients, East Jakarta, Indonesia, 2011-2014. Emerg Infect Dis. 2019;25(11):2031-9.
Kosen S, Indriasih E, Rosita T, Setiawaty V, Karyana M, Kosasih H, Rengganis I, Taurel AF, Nealon J, Nawawi S, Kartasasmita C. Influenza disease burden and cost estimates in Indonesia. ResearchGate (poster). 2019.
Kementerian Kesehatan Republik Indonesia. Prevalensi Penyakit Jantung Berdasarkan Diagnosis Dokter pada Penduduk Semua Umur Menurut Provinsi. Survei Kesehatan Indonesia (SKI) 2023.
Satgas Imunisasi Dewasa PAPDI. Jadwal Imunisasi Dewasa 2025. Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Anshari Saifuddin Hasibuan, Alvina Widhani, Sukamto Koesnoe, Suzy Maria, Eka Ginanjar, Sally Aman Nasution
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
